Punjab & Sind Bank — Others, 08-07-2025: Copy of Newspaper Publication

Punjab & Sind Bank has announced a board meeting to consider the financial results for the quarter and half-year. Separately, a court-ordered expert panel led by the Drug Controller General of India is expected to be set up soon to study the unregulated use of weight-loss drugs like semaglutide and tirzepatide following a public interest litigation highlighting safety concerns. In insolvency news, lenders evaluating resolution plans for JaiPrakash Associates Ltd are focusing on upfront cash and overall bid value amid ongoing Supreme Court review of a key land dispute. The Adani group leads with a ~₹12,250 Cr bid, seen as the most reliable despite legal risks.